Rockwell Medical annual operating margin
2017
2018
2019
2020
2021
2022
2023
2024
2025
Rockwell Medical's operating margin was −6.77% for fiscal 2025.
View full Rockwell Medical company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −6.77% | −7.37 pp |
| 2024 | 2024-12-31 | 0.60% | +8.58 pp |
| 2023 | 2023-12-31 | −7.98% | +15.07 pp |
| 2022 | 2022-12-31 | −23.05% | +25.94 pp |
| 2021 | 2021-12-31 | −48.98% | −3.29 pp |
| 2020 | 2020-12-31 | −45.69% | +10.63 pp |
| 2019 | 2019-12-31 | −56.32% | −5.14 pp |
| 2018 | 2018-12-31 | −51.18% | −5.93 pp |
| 2017 | 2017-12-31 | −45.24% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −5.97% | +2.43 pp |
| Q1 2026 | 2026-03-31 | −8.54% | −1.35 pp |
| Q4 2025 | 2025-12-31 | −2.17% | −0.07 pp |
| Q3 2025 | 2025-09-30 | −9.95% | −16.78 pp |
| Q2 2025 | 2025-06-30 | −8.39% | −10.39 pp |
| Q1 2025 | 2025-03-31 | −7.19% | −1.35 pp |
| Q4 2024 | 2024-12-31 | −2.10% | +0.37 pp |
| Q3 2024 | 2024-09-30 | 6.84% | +14.14 pp |
| Q2 2024 | 2024-06-30 | 1.99% | +18.36 pp |
| Q1 2024 | 2024-03-31 | −5.84% | +1.42 pp |
| Q4 2023 | 2023-12-31 | −2.48% | +7.69 pp |
| Q3 2023 | 2023-09-30 | −7.31% | +12.53 pp |
| Q2 2023 | 2023-06-30 | −16.37% | +7.62 pp |
| Q1 2023 | 2023-03-31 | −7.26% | +33.84 pp |
| Q4 2022 | 2022-12-31 | −10.17% | +44.35 pp |
| Q3 2022 | 2022-09-30 | −19.84% | +23.77 pp |
| Q2 2022 | 2022-06-30 | −23.99% | +27.69 pp |
| Q1 2022 | 2022-03-31 | −41.09% | +5.32 pp |
| Q4 2021 | 2021-12-31 | −54.52% | −1.29 pp |
| Q3 2021 | 2021-09-30 | −43.61% | +0.18 pp |
| Q2 2021 | 2021-06-30 | −51.68% | −16.43 pp |
| Q1 2021 | 2021-03-31 | −46.42% | +4.38 pp |
| Q4 2020 | 2020-12-31 | −53.23% | −5.45 pp |
| Q3 2020 | 2020-09-30 | −43.78% | +7.77 pp |
| Q2 2020 | 2020-06-30 | −35.25% | +34.61 pp |
| Q1 2020 | 2020-03-31 | −50.80% | +5.82 pp |
| Q4 2019 | 2019-12-31 | −47.79% | +8.13 pp |
| Q3 2019 | 2019-09-30 | −51.55% | −21.57 pp |
| Q2 2019 | 2019-06-30 | −69.86% | +12.60 pp |
| Q1 2019 | 2019-03-31 | −56.62% | −18.36 pp |
| Q4 2018 | 2018-12-31 | −55.92% | +6.23 pp |
| Q3 2018 | 2018-09-30 | −29.98% | +4.38 pp |
| Q2 2018 | 2018-06-30 | −82.46% | −31.72 pp |
| Q1 2018 | 2018-03-31 | −38.26% | −4.28 pp |
| Q4 2017 | 2017-12-31 | −62.15% | — |
| Q3 2017 | 2017-09-30 | −34.36% | — |
| Q2 2017 | 2017-06-30 | −50.73% | — |
| Q1 2017 | 2017-03-31 | −33.98% | — |
Over the last five reported fiscal years, Rockwell Medical's operating margin increased from −45.69% to −6.77%, a change of +38.92 percentage points. The latest reported quarter, Q2 2026, shows −5.97%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Rockwell Medical filings at SEC.gov ↗